富国恒生港股通创新药及医疗保健ETF发起式联接A(020110)份额变动
| 截止日 |
期初份额(份) |
期末份额(份) |
期间申购份额(份) |
期间赎回份额(份) |
| 2025-09-29 |
76,601,871.82 |
99,561,821.13 |
130,228,392.54 |
107,268,443.23 |
| 2025-06-29 |
43,890,569.81 |
76,601,871.82 |
77,111,837.29 |
44,400,535.28 |
| 2025-03-30 |
14,846,232.27 |
43,890,569.81 |
37,423,974.70 |
8,379,637.16 |
| 2024-12-30 |
16,162,762.27 |
14,846,232.27 |
2,824,159.62 |
4,140,689.62 |
| 2024-09-29 |
13,544,631.33 |
16,162,762.27 |
4,089,920.67 |
1,471,789.73 |
| 2024-06-29 |
10,723,924.08 |
13,544,631.33 |
6,574,807.72 |
3,754,100.47 |
| 2024-03-30 |
10,078,767.02 |
10,723,924.08 |
786,059.90 |
140,902.84 |
微信公众号
证券之星APP
基本资料
